TEAD3 and neoplasm: Subcutaneous injection of TEAD3-KO and wild-type (WT) cells into mice revealed that TEAD3 deficiency significantly reduced tumor growth, as evidenced by lighter tumor weight (Fig. 3J) and decreased bioluminescent signal intensity in live animal imaging (Fig. 3I).